| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |